633 results on '"Bourin,Michel"'
Search Results
52. Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors
53. The Four-Plate Test in Mice
54. Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?
55. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system
56. Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice
57. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze
58. The Mouse Light–Dark Box Test
59. The Forced Swimming Test in Mice: A Suitable Model to Study Antidepressants
60. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4
61. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice
62. Topiramate and phenytoin anti-immobility effect in the mice forced swimming test is reversed by veratrine: Implication for bipolar depression treatment
63. Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI
64. Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances
65. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety
66. An Overview of the Clinical Pharmacokinetics of X-Ray Contrast Media
67. Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?
68. Antidepressant-like effect of lamotrigine is reversed by veratrine: A possible role of sodium channels in bipolar depression
69. Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test
70. An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
71. Animal models of anxiety in mice
72. Temporal parameters of one-trial tolerance to benzodiazepines in four-plate test–retest
73. Bipolar disorder: How far are we from a rigorous definition and effective management?
74. Anxiolytic-like effect of 5-HT2 ligands and benzodiazepines co-administration: Comparison of two animal models of anxiety (the four-plate test and the elevated plus maze)
75. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze
76. Role of N-methyl-d-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats
77. Aripiprazole: a new treatment for schizophrenia
78. The four-plates test: Anxiolytic or analgesic paradigm?
79. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice
80. Light/dark cycle manipulation influences mice behaviour in the elevated plus maze
81. Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers
82. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests
83. α2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice
84. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: Double-blind, randomised, comparative 12-week trial
85. Anxiolytic-like effect of milnacipran in the four-plate test in mice: Mechanism of action
86. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze
87. Treatment of acute mania—from clinical trials to recommendations for clinical practice
88. Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxiety
89. Lamotrigine-Induced Neutropenia Following Two Attempts to Increase Dosage Above 50 mg/day with Recovery Between Episodes
90. An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
91. Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances?
92. Dopamine, depression and antidepressants
93. Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test?
94. Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice
95. Cholecystokinin and panic disorder
96. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors
97. Population pharmacokinetics of imipenem in burn patients
98. Population pharmacokinetics of ceftazidime in burn patients
99. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice
100. Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.